Albireo Pharma Inc (ALBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,358 | -12,847 | -6,671 | -16,350 | -5,130 |
| Depreciation Amortization | 410 | 314 | 176 | 1,079 | 855 |
| Accounts receivable | -321 | -265 | -274 | 1,104 | 1,271 |
| Accounts payable and accrued liabilities | 465 | 280 | 334 | -1,164 | -870 |
| Other Working Capital | -2,690 | -3,695 | -3,772 | 3,267 | 2,293 |
| Other Operating Activity | 1,873 | 1,785 | 1,678 | 3,280 | -743 |
| Operating Cash Flow | $-19,621 | $-14,428 | $-8,529 | $-8,784 | $-2,324 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -187 | -146 | -95 | -3 | -3 |
| Net Acquisitions | N/A | N/A | N/A | 25,483 | N/A |
| Investing Cash Flow | $-187 | $-146 | $-95 | $25,480 | $-3 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -2,159 | -1,648 | -789 | -2,157 | -1,427 |
| Common Stock Issued | 48,500 | 48,508 | 0 | 79 | 79 |
| Other Financing Activity | 226 | 62 | 0 | 9,690 | 0 |
| Financing Cash Flow | $46,567 | $46,922 | $-789 | $7,612 | $-1,348 |
| Exchange Rate Effect | 383 | 319 | -375 | 503 | 270 |
| Beginning Cash Position | 29,931 | 29,931 | 29,931 | 5,120 | 5,120 |
| End Cash Position | 57,073 | 62,598 | 20,143 | 29,931 | 1,715 |
| Net Cash Flow | $27,142 | $32,667 | $-9,788 | $24,811 | $-3,405 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,621 | -14,428 | -8,529 | -8,784 | -2,324 |
| Capital Expenditure | -187 | -146 | -95 | -3 | -3 |
| Free Cash Flow | -19,808 | -14,574 | -8,624 | -8,787 | -2,327 |